Latest round: IPO. Mark Jacobson has served as the Chief Operating Officer of Axsome Therapeutics since March 2020 and has been part of the Axsome team since.
Mark Jacobson has served as the Chief Operating Officer of Axsome Therapeutics since March 2020 and has been part of the Axsome team since April 2014. Before joining Axsome, he was the Director of Corporate Development at Stemline Therapeutics, Inc., where he was involved in investor relations, public relations, corporate operations, and intellectual property.
Full founder directory · Investor directory · Company funding database · Fundraising library